2-酰肼基-5-(2,4-二氯苯基)-1,3,4-噁二唑的合成及环化反应研究

二唑衍生物具有抗菌、消炎和调节植物生长等活性［１～５］．二唑硫醚衍生物也具有一定抗菌活性［６］．为筛选具有生物活性的新化合物和研究亲核取代反应的规律,我们设计和合成了新的２－酰肼基－５－（２,４－二氯苯基）－１,３,４－二唑２,研究了２在Ｋ２Ｃ...     

2,5-二吡唑基-1,3,4-(口恶)二唑的一锅煮法合成及生物活性

1,3,4-(口恶)二唑类化合物具有广泛的生物生理活性,如杀菌[1]、除草[2]、杀虫[3]和消炎[4]等,而2,5-二芳基-1,3,4-(口恶)二唑类化合物一般具有昆虫生长调节活性,1980年美国Dow公司报道了2,5-双(2,4-二氯苯基)-1,3,4-(口恶)二唑具有良好的昆虫生长调节活性[5].     

均三嗪基修饰的1,3,4-(口恶)二唑类化合物的合成

1,3,4-(口恶)二唑类材料[1-2]具有优良的电子传输性及很好的耐热性和抗氧化性,是目前应用最广泛的电子传输材料.然而由于小分子化合物性质不稳定,尤其是其热稳定性差以及易重结晶,从而影响电致发光器件的使用寿命.本文引入均三嗪基团对其进行化学修饰以改善其电子传输性能和稳定性,合成了几种2-苯基-5-(对氨基苯基)-1,3,4-(口恶)二唑取代的二氯均三嗪及其衍生物.合成路线如下.     

含有异(口恶)唑的S-三唑[3,4-b]-1,3,4-噻二嗪、咪唑[2,1-b]-1,3,4-噻二唑和咪唑[2,1-b]-1,3,4-(口恶)二唑衍生物的合成

异噁唑衍生物作为一类重要的生物活性物质[1,2],其合成一直受到人们的关注,其中德国HMR公司开发研制的新型抗内风湿性关节炎药来氟米特(Leftunomide)已于1998年在美国率先上市,该药还具有很好的免疫调节作用[3].7H-均三唑[3,4-b]-1,3,4-噻二嗪、咪唑并[2,1-b]噻唑和咪唑并[2,1-b]-1,3,4-噻二唑衍生物均表现出广谱的生物活性[4～6].     

1,3-偶极环加成合成新型含2-苯基-1,2,3-三唑基的1,2,4-(口恶)二唑啉衍生物

Schiff碱3和肟或氯代肟在三乙胺作用下通过1,3-偶极环加成生成一系列含2-苯基-1,2,3-三唑基的1,2,4-(口恶)二唑啉类化合物4a～4g, 5a～5g和6a～6g. 21个新化合物的结构经元素分析,1H NMR, IR 和MS谱确证.     

2-氨基-5-取代-1,3,4-噻二唑与2-氯代-1-(2,4-二氯苯基)乙酮的反应研究

2-氨基-5-烷基/芳基1,3,4-噻二唑与2-氯代-1-(2′,4′-二氯苯基)乙酮在热乙醇中反应生成一系列2-烷基/芳基-6-(4,4-二氯)苯基咪唑并[2-1-b]-1,3,4-噻二唑.产物通过元素分析, IR, 1H NMR, 13C NMR及MS分析,化合物5g的X衍射晶体结构分析表明,产物的芳基是在咪唑并[2-2-b]-1,3,4-噻二唑的6-位而不在5-位.     

5-苯基-2-(2’-苯基(口恶)唑基-5’)1,3,4-(口恶)二唑及其5-对位取代苯基衍生物的研究

合成了十二个未见报道的5-苯基-2-(2’-苯基(口恶)唑基-5’)1,3,4-(口恶)二唑及其5-对位取代苯基衍生物。测试了它们的紫外光谱、荧光光谱、荧光量于产率和激光转换效率,发现化合物的(?)和(?)与 Hammett 取代基常数|σ_p~+|有线性关系,化合物分子受激发后结构的平面性增加。     

邻溴苯基-2-(口恶)唑啉的合成研究

改进了邻溴苯基-2-(口恶)唑啉的合成方法,使得N-(β-羟乙基)-2-(口恶)溴苯甲酰胺在氯化亚砜作用下缩合成唑啉的收率从40%左右提高到84%,并避免了使用NaH试剂,为芳基-2-(口恶)唑啉的合成提供一条方便、经济的路线.实验结果表明,反应温度对唑啉的收率的影响显著,随着反应温度的升高收率明显降低,室温下几乎得不到目标产物.根据实验结果推测其反应过程是经过互变异构酰亚胺中间物Ⅰ进行的.     

5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基吡唑-3-羧酸的合成

对氯苯丙酮经三甲基氯硅烷保护后与草酸单乙酯单酰氯缩合制得4-(4-氯苯基)-3-甲基-2,4-二氧代丁酸乙酯(4);4与2,4-二氯苯肼盐酸盐缩合成腙、再经分子内环合、水解合成了制备利莫那班的关键中间体——5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基吡唑-3-羧酸,总收率30.3%,其结构经1HNMR和MS确证。     

Synthesis of 2,4-Diamino-5-Cinnamoylthiazoles and Their Attempted Cyclization

Synthesis of 4-amino-2-aryl(or alkyl)amino-5-cinnamoylthiazoles by a [(C ─ N ─ C ─ S) + C] ring construction route is reported. Unlike the analogous 2′-aminochalcones, neither do these thiazoles cyclize to bicyclic pyridones, nor could these be prepared from the corresponding 5-acetylthiazoles and benzaldehyde.     

1,2,3-Selenadiazolyl-1,3,4-oxadiazole, 1,2,3-Thiadiazolyl-1,3,4-oxadiazole and 5-(1,2,3-Thiadiazolyl)-s-triazolo[3,4-b]-1,3,4-thiadiazoles

A series of 5-substituted-2-(4-alkyl or phenyl-1,2,3-thia(or selena)diazol-5-yl)-1,3,4-oxadiazoles were prepared. 5-Substituted-2-(4-phenyl-1,2,3-selenadiazol-5-yl)-1,3,4-oxadiazoles upon pyrolysis afforded the corresponding alkynes. Also, a series of 5-substituted-4-amino-3-(1,2,3-thiadiazol-5-yl)-s-triazoles and 5-(1,2,3-thiadiazolyl)-s-triazolo[3,4-b]-1,3,4-thiadiazoles were prepared.     

Synthesis and Crystal Structure of 2-（ 4-Decarboxydehydroabietyl）- 5-p-tolyl-[ 1,3,4 ]-oxadiazole

2-（4-Decarboxydehydroabietyl）-5-p-toyl-[1,3,4]-oxadiazole, C28H34N2O, has been synthesized and characterized by IR, NMR, elemental analysis and single-crystal X-ray diffraction method. The crystal belongs to the orthorhombic system, space group P212121 with a = 6.1351（5）, b = 14.8495（19）, c = 25.9050（2） A, V = 2360.0（4） A3, Z = 4, Mr = 414.57, Dc = 1.167 Mg/m^3, 2 = 0.71073 A,μ（MoKa） = 0.070 mm^-1, F（000） = 896, the final R = 0.0452 and wR = 0.1076 for 1647 observed reflections with I 〉 2σ（I）. There are five rings in the crystal structure of the title compound, but the oxadiazole ring is non-coplanar with the benzene ring D.     

Synthesis and bioactivities of novel 2-(thioether/sulfone)-5-pyrazolyl-1,3,4-oxadiazole derivatives

By introducing the pyrazole moiety into the 5-position of 1,3,4-oxadiazole,a series of novel 2-(thioether/sulfone)-5-pyrazolyl-l,3,4-oxadiazole derivatives were synthesized.Preliminary bioassays suggested that target compounds exhibited appreciable activity against pathogenic bacteria Xanthomonas oryzae pv.oryzae(Xoo) and five phytopathogenic fungi in vitro.Among them,the half-maximal effective concentration(EC_(50)) values of 6c,7a,7b and 7c against Xoo were within 16.6 μg/mL and 65.7 μg/mL,which were better than those of commercial agricultural antibacterial bismerthiazol(92.6 μg/mL) and thiodiazole copper(121.8 μg/mL).While compounds 7a,7b,and 7c exerted comprehensive antifungal activity toward five plant fungi,which were comparable with that of hymexazol.The results demonstrated that this kind of compounds can be further studied and developed as promising antifungal and antibacterial agents.     

2-取代苯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噁二唑衍生物的合成及生物活性研究

合成了10个2-取代苯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噁二唑衍生物. 并经过元素分析, IR, ¹H NMR, ¹³C NMR对其结构进行了确认. 初步生物活性测试表明, 部分化合物具有一定抗癌活性.     

Synthesis and spectral luminescence properties of 2-aryl-5-methyl-1,3,4-oxadiazoles and zinc(ii) 2-(2-hydroxyphenyl)-5-methyl-1,3,4-oxadiazole complex

Russian Chemical Bulletin - 2-Aryl-5-methyl-1,3,4-oxadiazoles were synthesized by reflux of equimolar amounts of acyl hydrazides with triethyl orthoacetate in o-xylene. The obtained oxadiazoles,...     

Synthesis and characterization of poly(1-benzoylsemicarbazide) and poly(1,3,4-oxadiazole amine) from 2-(p-aminophenyl)-1,3,4-oxadizolin-5-one via ring-opening

A novel thermally stable and semiconducting polyheterocycle, poly(1,3,4-oxadiazole amine), was synthesized from 2-(p-aminophenyl)-1,3,4-oxadiazolin-5-one via ring-opening. The polymer is a new class of ordered alternating copoly(aniline) containing 1,3,4-oxadiazole heterocyclic units. The polymer is highly thermally stable and exhibits no weight loss up to 370°C in air. Its electric conductivity is less than 10⁻¹⁰ S · cm⁻¹ at ambient temperature, but markedly increases to 6,5 · 10⁻⁷ S · cm⁻¹ upon doping with iodine.